In nondiabetic and prediabetic individuals, insulin sensitivity and secretion do not predict spontaneous weight changes; whereas, baseline waist circumference is a positive, independent predictor of weight gain and loss.…

Older type 2’s improve cardiovascular risks when using insulin and targeting postprandial versus fasting glycemia.…

When making a choice amongst GLP-1 Agonists, the number of injections per day and when peak concentrations are reached are both important in selecting therapy. There was almost unanimous consensus that Exenatide is administered twice daily while Liraglutide is given only one time a day. It was interesting to note …

This week we get back to our interview with Dr. Aaron Vinik, Director, EVMS Strelitz Diabetes Research Center. He has been at the forefront in developing new technologies for growing and regenerating beta cells. Our publisher, Steve Freed, had a few questions for him on how he views the use …

Many times our patients get a Glucagon Kit when they start on insulin and since most patients are taught to only use the injection if they are unconscious, they never use it. However, in this week’s Diabetes Disaster Averted, the use of part of a glucagon injection kit was very …

Edited by Trisha Dunning AM, RN, MEd, PhD, CDE, FRCNA and Glenn Ward MBBS, BSc, DPhil (Oxon), FRACP, FRCPath Mrs. MJ was referred to a diabetes centre by her GP.  Mrs. MJ, a 60-year-old woman with type 2 diabetes since 2000, presents with…

From Part 5 of our series on diabetic eye disease: "Chronic hyperglycemia unleashes a progressive cascade of events: Endothelial pericyte loss; RGC death; Increased vascular permeability; Capillary; Release of vasoproliferative factors; and Neovascularization, fibrovascular vitreo-retinal adhesions, vitreous hemorrhage."….

Drugs Show Promise for Preserving Body’s Ability to Produce Insulin The progression of type 1 diabetes may be slowed in those newly diagnosed through the use of promising new medications currently under development, according to data presented by researchers at the American Diabetes Association’s 71st Scientific Sessions®. Researchers believe these …

  GlucaPen™ Glucagon without prior mixing   GlucaPen is an auto-injector pen containing glucagon which is substantially different from the currently marketed hypo-kits. The design integrates the glucagon powder and diluent into a dual chamber cartridge within the pen. The pen also has a pre-attached needle which is only activated …

A recent meta-analysis found a link between statin therapy and increased risk of developing new onset diabetes. The researchers found: “In 5 statin trials with 32,752 participants without diabetes at baseline, 2749 developed diabetes and 6684 experienced cardiovascular events for new-onset diabetes and 0.84 for cardiovascular events for participants receiving …